• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ASCO: Cymbalta Tames Post-Chemo Pain

Article

The antidepressant duloxetine (Cymbalta) appears to cut down on the numbness and tingling associated with taxane or platinum-based chemotherapy, according to clinical trial results.

Pain from chemotherapy-induced peripheral neuropathy and its interference with daily life fell significantly with the drug, Ellen Lavoie Smith, PhD, of the University of Michigan School of Nursing in Ann Arbor, and colleagues found.

A clinically significant 30% or greater reduction in pain scores occurred in 33% of duloxetine-treated patients compared with 17% of placebo-treated patients, they reported here at the American Society of Clinical Oncology meeting.

Read the full story: http://hcp.lv/Lv6TA7

Source: MedPage Today

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Justin Oldham, MD, MS, an expert on IPF
Ruben Mesa, MD
Amit Garg, MD, Northwell Health
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.